To the full analysis
Molina Healthcare stock: growth
MOHMolina Healthcare reported $45.43B in revenue for fiscal 2025, up 11.7% on the prior year, up 18.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
17.8%
per year from 2006 to 2025, per share 16.7%
Earnings (Annual rate)
13.1%
per year from 2006 to 2025, per share 11.7%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 18.5% | 12.4% | 17.8% |
| Revenue per share | 22.1% | 12.7% | 16.7% |
| Earnings | −6.8% | 12.7% | 13.1% |
| Earnings per share | −4.8% | 12.5% | 11.7% |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $2B | $45.73M | $82.02M |
| 2007 | $2.49B | $58.33M | $136.33M |
| 2008 | $3.11B | $62.4M | $5.74M |
| 2009 | $3.67B | $30.87M | $119.11M |
| 2010 | $4.09B | $54.97M | $113.11M |
| 2011 | $4.77B | $20.82M | $164.81M |
| 2012 | $6.03B | $9.79M | $266.15M |
| 2013 | $6.59B | $52.93M | $92.03M |
| 2014 | $9.67B | $62.22M | $945.32M |
| 2015 | $14.07B | $143M | $993M |
| 2016 | $17.71B | $8M | $497M |
| 2017 | $19.88B | −$512M | $718M |
| 2018 | $18.89B | $707M | −$344M |
| 2019 | $16.83B | $737M | $370M |
| 2020 | $19.42B | $673M | $1.82B |
| 2021 | $27.77B | $659M | $2.04B |
| 2022 | $31.97B | $792M | $682M |
| 2023 | $34.07B | $1.09B | $1.58B |
| 2024 | $40.65B | $1.18B | $544M |
| 2025 | $45.43B | $472M | −$636M |
Revenue by segment
How Molina Healthcare, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Medicaid Solutions71%
- Medicare14%
- Marketplace10%
- Other5%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2024 | 2025 | Share 2025 | |
|---|---|---|---|
| Medicaid Solutions | $30.58B | $32.24B | 71% |
| Medicare | $5.54B | $6.24B | 13.7% |
| Marketplace | $2.51B | $4.49B | 9.9% |
| Other | $2.02B | $2.46B | 5.4% |
| Total revenue | $40.65B | $45.43B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 12 Nov 2026, previously Weak
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.